Search research articles
Contact Us
Filters
Showing results (51-60 of 223) with videos related to
Page
of 23
Sort By:
Kidney International
|
May 1, 1992
Atrial natriuretic factor: its (patho)physiological significance in humans
D de Zeeuw, W M Janssen, P E de Jong
The Canadian Journal of Cardiology
|
August 1, 1995
Losartan in patients with renal insufficiency
D de Zeeuw, R T Gansevoort, P E de Jong
Seminars in Nephrology
|
December 26, 2001
Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease
A Boonstra, D de Zeeuw, P E de Jong, et al.
Clinical Science (London, England : 1979)
|
December 1, 1998
Erythrocyte Na+/Li+ countertransport and Na+/K+-2Cl- co-transport measurement in essential hypertension: useful diagnostic tools or failure? A meta-analysis of 17 years of literature
T Tepper, W J Sluiter, R M Huisman, et al.
Kidney International
|
April 1, 1993
Quantification of renal low-molecular-weight protein handling in the intact rat
M Haas, D de Zeeuw, A van Zanten, et al.
British Journal of Pharmacology
|
March 27, 2001
Intracellular Angiotensin II and cell growth of vascular smooth muscle cells
C M Filipeanu, R H Henning, D de Zeeuw, et al.
Pharmaceutical Research
|
July 1, 1993
Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid
E J Franssen, F Moolenaar, D de Zeeuw, et al.
Nephron
|
January 1, 1978
Nephroptosis and kidney function
D de Zeeuw, A J Donker, G van Herk, et al.
Kidney International. Supplement
|
January 4, 1998
Renal hemodynamic effects of candesartan in normal and impaired renal function in humans
H Buter, G Navis, D de Zeeuw, et al.
Contributions to Nephrology
|
January 1, 1993
Low-molecular-weight proteins as carriers for renal drug targeting
E J Franssen, F Moolenaar, D de Zeeuw, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 223) with videos related to
Sort By:
Page
of 23
Kidney International
|
May 1, 1992
Atrial natriuretic factor: its (patho)physiological significance in humans
D de Zeeuw, W M Janssen, P E de Jong
The Canadian Journal of Cardiology
|
August 1, 1995
Losartan in patients with renal insufficiency
D de Zeeuw, R T Gansevoort, P E de Jong
Seminars in Nephrology
|
December 26, 2001
Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease
A Boonstra, D de Zeeuw, P E de Jong, et al.
Clinical Science (London, England : 1979)
|
December 1, 1998
Erythrocyte Na+/Li+ countertransport and Na+/K+-2Cl- co-transport measurement in essential hypertension: useful diagnostic tools or failure? A meta-analysis of 17 years of literature
T Tepper, W J Sluiter, R M Huisman, et al.
Kidney International
|
April 1, 1993
Quantification of renal low-molecular-weight protein handling in the intact rat
M Haas, D de Zeeuw, A van Zanten, et al.
British Journal of Pharmacology
|
March 27, 2001
Intracellular Angiotensin II and cell growth of vascular smooth muscle cells
C M Filipeanu, R H Henning, D de Zeeuw, et al.
Pharmaceutical Research
|
July 1, 1993
Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid
E J Franssen, F Moolenaar, D de Zeeuw, et al.
Nephron
|
January 1, 1978
Nephroptosis and kidney function
D de Zeeuw, A J Donker, G van Herk, et al.
Kidney International. Supplement
|
January 4, 1998
Renal hemodynamic effects of candesartan in normal and impaired renal function in humans
H Buter, G Navis, D de Zeeuw, et al.
Contributions to Nephrology
|
January 1, 1993
Low-molecular-weight proteins as carriers for renal drug targeting
E J Franssen, F Moolenaar, D de Zeeuw, et al.
Page
of 23